Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Mechanisms coupling thrombomodulin to tumor dissemination.

Horowitz NA, Palumbo JS.

Thromb Res. 2012 Apr;129 Suppl 1:S119-21. doi: 10.1016/S0049-3848(12)70030-0. No abstract available.

PMID:
22682121
[PubMed - indexed for MEDLINE]
2.

Role of inflammatory cells and mediators in tumor invasion and metastasis.

Mantovani A.

Cancer Metastasis Rev. 2010 Jun;29(2):241. doi: 10.1007/s10555-010-9228-1. No abstract available.

PMID:
20397039
[PubMed - indexed for MEDLINE]
3.

Simple biophysical model of tumor evasion from immune system control.

d'Onofrio A, Ciancio A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Sep;84(3 Pt 1):031910. Epub 2011 Sep 12.

PMID:
22060406
[PubMed - indexed for MEDLINE]
4.

Inflammation-mediated promotion of invasion and metastasis.

Solinas G, Marchesi F, Garlanda C, Mantovani A, Allavena P.

Cancer Metastasis Rev. 2010 Jun;29(2):243-8. doi: 10.1007/s10555-010-9227-2. Review.

PMID:
20414701
[PubMed - indexed for MEDLINE]
5.

Thrombomodulin immunoreactivity in adenomatoid tumour of the uterus.

Shintaku M, Sasaki M, Honda T.

Histopathology. 1996 Apr;28(4):375-7. No abstract available.

PMID:
8732350
[PubMed - indexed for MEDLINE]
6.
7.

Tumorigenicity and dissemination of human tumors in congenitally immune-deficient mice.

Fodstad O.

J Natl Cancer Inst. 1991 Oct 2;83(19):1419-20. No abstract available.

PMID:
1920486
[PubMed - indexed for MEDLINE]
8.

Thrombomodulin and its role in inflammation.

Conway EM.

Semin Immunopathol. 2012 Jan;34(1):107-25. doi: 10.1007/s00281-011-0282-8. Epub 2011 Jul 31. Review.

PMID:
21805323
[PubMed - indexed for MEDLINE]
9.

Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma.

Attanoos RL, Goddard H, Gibbs AR.

Histopathology. 1996 Sep;29(3):209-15.

PMID:
8884348
[PubMed - indexed for MEDLINE]
10.

CD44 splice variants; expression on lymphocytes and in neoplasia.

Koopman G, Griffioen AW, Ponta H, Herrlich P, van den Berg F, Manten-Horst E, Pals ST.

Res Immunol. 1993 Nov-Dec;144(9):750-4; discussion 754-62. Review. No abstract available.

PMID:
7512745
[PubMed - indexed for MEDLINE]
11.

Is CD146 pivotal in neoplasm invasion and blastocyst embedding?

Chen W, Cao G, Zhang SL.

Med Hypotheses. 2011 Mar;76(3):378-80. doi: 10.1016/j.mehy.2010.10.045. Epub 2010 Nov 20.

PMID:
21095067
[PubMed - indexed for MEDLINE]
12.

Self-organization and competition in the immune response to cancer invasion: a phase-orientated computational model of oncogenesis.

Oprişan SA, Ardelean A, Frangopol PT.

Bioinformatics. 2000 Feb;16(2):96-100.

PMID:
10842728
[PubMed - indexed for MEDLINE]
Free Article
13.

Tumor versus tumor-associated macrophages: how hot is the link?

Guruvayoorappan C.

Integr Cancer Ther. 2008 Jun;7(2):90-5. doi: 10.1177/1534735408319060. Review.

PMID:
18550889
[PubMed - indexed for MEDLINE]
14.

Chemokines: not just leukocyte chemoattractants in the promotion of cancer.

Strieter RM.

Nat Immunol. 2001 Apr;2(4):285-6. No abstract available.

PMID:
11276195
[PubMed - indexed for MEDLINE]
15.

Mast cell: insight into remodeling a tumor microenvironment.

Liu J, Zhang Y, Zhao J, Yang Z, Li D, Katirai F, Huang B.

Cancer Metastasis Rev. 2011 Jun;30(2):177-84. doi: 10.1007/s10555-011-9276-1. Review.

PMID:
21267769
[PubMed - indexed for MEDLINE]
16.

Functional and immunoreactive thrombomodulin expressed by keratinocytes.

Mizutani H, Hayashi T, Nouchi N, Ohyanagi S, Hashimoto K, Shimizu M, Suzuki K.

J Invest Dermatol. 1994 Dec;103(6):825-8.

PMID:
7798622
[PubMed - indexed for MEDLINE]
17.

Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer.

Liu PL, Tsai JR, Chiu CC, Hwang JJ, Chou SH, Wang CK, Wu SJ, Chen YL, Chen WC, Chen YH, Chong IW.

Mol Carcinog. 2010 Oct;49(10):874-81. doi: 10.1002/mc.20663.

PMID:
20607726
[PubMed - indexed for MEDLINE]
18.

[The role of stromal mast cells in the modification of CD4+CD25+Foxp³ regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor].

Starska K, Brzezińska-Błaszczyk E.

Postepy Hig Med Dosw (Online). 2010 Aug 23;64:408-16. Review. Polish.

PMID:
20966498
[PubMed - indexed for MEDLINE]
Free Article
19.

Spatiotemporal effects of a possible chemorepulsion of tumor cells by immune system effectors.

d'Onofrio A.

J Theor Biol. 2012 Mar 7;296:41-8. doi: 10.1016/j.jtbi.2011.11.013. Epub 2011 Nov 19.

PMID:
22119911
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk